Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GTS21 in adults with ADHD
NCT00419445Phase 2Completed
- Sponsor
- CoMentis, Inc.
- Start
- Feb 2007
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dmxb-a in attention deficit hyperactivity disorder (ADHD), sponsored by CoMentis, Inc.. Started Feb 2007; status: completed.
02
Drugs
dmxb-a
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00419445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00419445.